Reviewer's report
Title:Management of the HBV reactivation in isolated HBcAb positive patients
affected with Non Hodgkin Lymphoma
Version:2Date:15 December 2013
Reviewer: Savino Bruno
Reviewer's report:
This article highiltighs that 1 out of 10 patients with HB core positivity regardless
HBs ag negativity may experienced reactiviation while receving
immunosuppressive therapy for NH lynphoma, I suggest, on the basis of the low
cost of therapy, that they will change their conclusion suggesting lamivudine
prophilaxis for all HB core *ve patients.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests' below. If your reply is yes to any,
please give details below.No
Reviewer's report
Title:Management of the HBV reactivation in isolated HBcAb positive patients
affected with Non Hodgkin Lymphoma
Version:2Date:15 December 2013
Reviewer: Savino Bruno
Reviewer's report:
This article highiltighs that 1 out of 10 patients with HB core positivity regardless
HBs ag negativity may experienced reactiviation while receving
immunosuppressive therapy for NH lynphoma, I suggest, on the basis of the low
cost of therapy, that they will change their conclusion suggesting lamivudine
prophilaxis for all HB core *ve patients.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests' below. If your reply is yes to any,
please give details below.No
Please review this paper.
user
Reviewer's report
Title:Management of the HBV reactivation in isolated HBcAb positive patients
affected with Non Hodgkin Lymphoma
Version:2Date:15 December 2013
Reviewer: Savino Bruno
Reviewer's report:
This article highiltighs that 1 out of 10 patients with HB core positivity regardless
HBs ag negativity may experienced reactiviation while receving
immunosuppressive therapy for NH lynphoma, I suggest, on the basis of the low
cost of therapy, that they will change their conclusion suggesting lamivudine
prophilaxis for all HB core *ve patients.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests' below. If your reply is yes to any,
please give details below.No
assistant